Cargando…
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
The coronavirus disease 2019 (COVID‐19) pandemic has affected a large portion of the global population, both physically and mentally. Current evidence suggests that the rapidly evolving coronavirus subvariants risk rendering vaccines and antibodies ineffective due to their potential to evade existin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/ https://www.ncbi.nlm.nih.gov/pubmed/37193304 http://dx.doi.org/10.1002/mco2.254 |